Virtu Financial LLC purchased a new stake in InterCure Ltd. (NASDAQ:INCR – Free Report) during the 3rd quarter, HoldingsChannel.com reports. The fund purchased 21,427 shares of the company’s stock, valued at approximately $43,000.
Several other hedge funds have also recently bought and sold shares of the stock. Jane Street Group LLC bought a new position in shares of InterCure during the third quarter worth approximately $49,000. Renaissance Technologies LLC boosted its stake in InterCure by 30.9% in the 2nd quarter. Renaissance Technologies LLC now owns 45,300 shares of the company’s stock valued at $91,000 after purchasing an additional 10,700 shares during the period. Finally, AdvisorShares Investments LLC acquired a new position in InterCure in the 2nd quarter valued at $218,000. 8.34% of the stock is currently owned by institutional investors and hedge funds.
InterCure Stock Performance
INCR stock opened at $1.49 on Friday. InterCure Ltd. has a fifty-two week low of $1.17 and a fifty-two week high of $3.72. The company has a current ratio of 1.78, a quick ratio of 1.15 and a debt-to-equity ratio of 0.15. The business’s fifty day moving average price is $1.51 and its two-hundred day moving average price is $1.91.
InterCure Company Profile
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Featured Stories
- Five stocks we like better than InterCure
- Buy P&G Now, Before It Sets A New All-Time High
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 2 Underrated Quantum Computing Companies Starting to Rally
Want to see what other hedge funds are holding INCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InterCure Ltd. (NASDAQ:INCR – Free Report).
Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.